img

Global Major Histocompatibility Complex Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Major Histocompatibility Complex Market Research Report 2024

The major histocompatibility complex (MHC) is a large locus on vertebrate DNA containing a set of closely linked polymorphic genes that code for cell surface proteins essential for the adaptive immune system.
According to Mr Accuracy reports’s new survey, global Major Histocompatibility Complex market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Major Histocompatibility Complex market research.
Key companies engaged in the Major Histocompatibility Complex industry include Miltenyi Biotec, Santa Cruz Biotechnology, Abbexa, ProImmune, Creative BioMart and Novus Biologicals, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Major Histocompatibility Complex were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Major Histocompatibility Complex market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Major Histocompatibility Complex market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Miltenyi Biotec
Santa Cruz Biotechnology
Abbexa
ProImmune
Creative BioMart
Novus Biologicals
Segment by Type
MHC Class I
MHC Class II
MHC Class III

Segment by Application


Medical Care
Research
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Major Histocompatibility Complex report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Major Histocompatibility Complex Market Size Growth Rate by Type: 2024 VS 2022 VS 2034
1.2.2 MHC Class I
1.2.3 MHC Class II
1.2.4 MHC Class III
1.3 Market by Application
1.3.1 Global Major Histocompatibility Complex Market Growth by Application: 2024 VS 2022 VS 2034
1.3.2 Medical Care
1.3.3 Research
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Major Histocompatibility Complex Market Perspective (2024-2034)
2.2 Major Histocompatibility Complex Growth Trends by Region
2.2.1 Global Major Histocompatibility Complex Market Size by Region: 2024 VS 2022 VS 2034
2.2.2 Major Histocompatibility Complex Historic Market Size by Region (2024-2024)
2.2.3 Major Histocompatibility Complex Forecasted Market Size by Region (2024-2034)
2.3 Major Histocompatibility Complex Market Dynamics
2.3.1 Major Histocompatibility Complex Industry Trends
2.3.2 Major Histocompatibility Complex Market Drivers
2.3.3 Major Histocompatibility Complex Market Challenges
2.3.4 Major Histocompatibility Complex Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Major Histocompatibility Complex Players by Revenue
3.1.1 Global Top Major Histocompatibility Complex Players by Revenue (2024-2024)
3.1.2 Global Major Histocompatibility Complex Revenue Market Share by Players (2024-2024)
3.2 Global Major Histocompatibility Complex Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Major Histocompatibility Complex Revenue
3.4 Global Major Histocompatibility Complex Market Concentration Ratio
3.4.1 Global Major Histocompatibility Complex Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Major Histocompatibility Complex Revenue in 2022
3.5 Major Histocompatibility Complex Key Players Head office and Area Served
3.6 Key Players Major Histocompatibility Complex Product Solution and Service
3.7 Date of Enter into Major Histocompatibility Complex Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Major Histocompatibility Complex Breakdown Data by Type
4.1 Global Major Histocompatibility Complex Historic Market Size by Type (2024-2024)
4.2 Global Major Histocompatibility Complex Forecasted Market Size by Type (2024-2034)
5 Major Histocompatibility Complex Breakdown Data by Application
5.1 Global Major Histocompatibility Complex Historic Market Size by Application (2024-2024)
5.2 Global Major Histocompatibility Complex Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Major Histocompatibility Complex Market Size (2024-2034)
6.2 North America Major Histocompatibility Complex Market Growth Rate by Country: 2024 VS 2022 VS 2034
6.3 North America Major Histocompatibility Complex Market Size by Country (2024-2024)
6.4 North America Major Histocompatibility Complex Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Major Histocompatibility Complex Market Size (2024-2034)
7.2 Europe Major Histocompatibility Complex Market Growth Rate by Country: 2024 VS 2022 VS 2034
7.3 Europe Major Histocompatibility Complex Market Size by Country (2024-2024)
7.4 Europe Major Histocompatibility Complex Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Major Histocompatibility Complex Market Size (2024-2034)
8.2 Asia-Pacific Major Histocompatibility Complex Market Growth Rate by Region: 2024 VS 2022 VS 2034
8.3 Asia-Pacific Major Histocompatibility Complex Market Size by Region (2024-2024)
8.4 Asia-Pacific Major Histocompatibility Complex Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Major Histocompatibility Complex Market Size (2024-2034)
9.2 Latin America Major Histocompatibility Complex Market Growth Rate by Country: 2024 VS 2022 VS 2034
9.3 Latin America Major Histocompatibility Complex Market Size by Country (2024-2024)
9.4 Latin America Major Histocompatibility Complex Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Major Histocompatibility Complex Market Size (2024-2034)
10.2 Middle East & Africa Major Histocompatibility Complex Market Growth Rate by Country: 2024 VS 2022 VS 2034
10.3 Middle East & Africa Major Histocompatibility Complex Market Size by Country (2024-2024)
10.4 Middle East & Africa Major Histocompatibility Complex Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Miltenyi Biotec
11.1.1 Miltenyi Biotec Company Detail
11.1.2 Miltenyi Biotec Business Overview
11.1.3 Miltenyi Biotec Major Histocompatibility Complex Introduction
11.1.4 Miltenyi Biotec Revenue in Major Histocompatibility Complex Business (2024-2024)
11.1.5 Miltenyi Biotec Recent Development
11.2 Santa Cruz Biotechnology
11.2.1 Santa Cruz Biotechnology Company Detail
11.2.2 Santa Cruz Biotechnology Business Overview
11.2.3 Santa Cruz Biotechnology Major Histocompatibility Complex Introduction
11.2.4 Santa Cruz Biotechnology Revenue in Major Histocompatibility Complex Business (2024-2024)
11.2.5 Santa Cruz Biotechnology Recent Development
11.3 Abbexa
11.3.1 Abbexa Company Detail
11.3.2 Abbexa Business Overview
11.3.3 Abbexa Major Histocompatibility Complex Introduction
11.3.4 Abbexa Revenue in Major Histocompatibility Complex Business (2024-2024)
11.3.5 Abbexa Recent Development
11.4 ProImmune
11.4.1 ProImmune Company Detail
11.4.2 ProImmune Business Overview
11.4.3 ProImmune Major Histocompatibility Complex Introduction
11.4.4 ProImmune Revenue in Major Histocompatibility Complex Business (2024-2024)
11.4.5 ProImmune Recent Development
11.5 Creative BioMart
11.5.1 Creative BioMart Company Detail
11.5.2 Creative BioMart Business Overview
11.5.3 Creative BioMart Major Histocompatibility Complex Introduction
11.5.4 Creative BioMart Revenue in Major Histocompatibility Complex Business (2024-2024)
11.5.5 Creative BioMart Recent Development
11.6 Novus Biologicals
11.6.1 Novus Biologicals Company Detail
11.6.2 Novus Biologicals Business Overview
11.6.3 Novus Biologicals Major Histocompatibility Complex Introduction
11.6.4 Novus Biologicals Revenue in Major Histocompatibility Complex Business (2024-2024)
11.6.5 Novus Biologicals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Major Histocompatibility Complex Market Size Growth Rate by Type (US$ Million): 2024 VS 2022 VS 2034
Table 2. Key Players of MHC Class I
Table 3. Key Players of MHC Class II
Table 4. Key Players of MHC Class III
Table 5. Global Major Histocompatibility Complex Market Size Growth by Application (US$ Million): 2024 VS 2022 VS 2034
Table 6. Global Major Histocompatibility Complex Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 7. Global Major Histocompatibility Complex Market Size by Region (2024-2024) & (US$ Million)
Table 8. Global Major Histocompatibility Complex Market Share by Region (2024-2024)
Table 9. Global Major Histocompatibility Complex Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 10. Global Major Histocompatibility Complex Market Share by Region (2024-2034)
Table 11. Major Histocompatibility Complex Market Trends
Table 12. Major Histocompatibility Complex Market Drivers
Table 13. Major Histocompatibility Complex Market Challenges
Table 14. Major Histocompatibility Complex Market Restraints
Table 15. Global Major Histocompatibility Complex Revenue by Players (2024-2024) & (US$ Million)
Table 16. Global Major Histocompatibility Complex Market Share by Players (2024-2024)
Table 17. Global Top Major Histocompatibility Complex Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Major Histocompatibility Complex as of 2022)
Table 18. Ranking of Global Top Major Histocompatibility Complex Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Major Histocompatibility Complex Revenue (CR5 and HHI) & (2024-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Major Histocompatibility Complex Product Solution and Service
Table 22. Date of Enter into Major Histocompatibility Complex Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Major Histocompatibility Complex Market Size by Type (2024-2024) & (US$ Million)
Table 25. Global Major Histocompatibility Complex Revenue Market Share by Type (2024-2024)
Table 26. Global Major Histocompatibility Complex Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 27. Global Major Histocompatibility Complex Revenue Market Share by Type (2024-2034)
Table 28. Global Major Histocompatibility Complex Market Size by Application (2024-2024) & (US$ Million)
Table 29. Global Major Histocompatibility Complex Revenue Market Share by Application (2024-2024)
Table 30. Global Major Histocompatibility Complex Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 31. Global Major Histocompatibility Complex Revenue Market Share by Application (2024-2034)
Table 32. North America Major Histocompatibility Complex Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 33. North America Major Histocompatibility Complex Market Size by Country (2024-2024) & (US$ Million)
Table 34. North America Major Histocompatibility Complex Market Size by Country (2024-2034) & (US$ Million)
Table 35. Europe Major Histocompatibility Complex Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 36. Europe Major Histocompatibility Complex Market Size by Country (2024-2024) & (US$ Million)
Table 37. Europe Major Histocompatibility Complex Market Size by Country (2024-2034) & (US$ Million)
Table 38. Asia-Pacific Major Histocompatibility Complex Market Size Growth Rate by Region (US$ Million): 2024 VS 2022 VS 2034
Table 39. Asia-Pacific Major Histocompatibility Complex Market Size by Region (2024-2024) & (US$ Million)
Table 40. Asia-Pacific Major Histocompatibility Complex Market Size by Region (2024-2034) & (US$ Million)
Table 41. Latin America Major Histocompatibility Complex Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 42. Latin America Major Histocompatibility Complex Market Size by Country (2024-2024) & (US$ Million)
Table 43. Latin America Major Histocompatibility Complex Market Size by Country (2024-2034) & (US$ Million)
Table 44. Middle East & Africa Major Histocompatibility Complex Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 45. Middle East & Africa Major Histocompatibility Complex Market Size by Country (2024-2024) & (US$ Million)
Table 46. Middle East & Africa Major Histocompatibility Complex Market Size by Country (2024-2034) & (US$ Million)
Table 47. Miltenyi Biotec Company Detail
Table 48. Miltenyi Biotec Business Overview
Table 49. Miltenyi Biotec Major Histocompatibility Complex Product
Table 50. Miltenyi Biotec Revenue in Major Histocompatibility Complex Business (2024-2024) & (US$ Million)
Table 51. Miltenyi Biotec Recent Development
Table 52. Santa Cruz Biotechnology Company Detail
Table 53. Santa Cruz Biotechnology Business Overview
Table 54. Santa Cruz Biotechnology Major Histocompatibility Complex Product
Table 55. Santa Cruz Biotechnology Revenue in Major Histocompatibility Complex Business (2024-2024) & (US$ Million)
Table 56. Santa Cruz Biotechnology Recent Development
Table 57. Abbexa Company Detail
Table 58. Abbexa Business Overview
Table 59. Abbexa Major Histocompatibility Complex Product
Table 60. Abbexa Revenue in Major Histocompatibility Complex Business (2024-2024) & (US$ Million)
Table 61. Abbexa Recent Development
Table 62. ProImmune Company Detail
Table 63. ProImmune Business Overview
Table 64. ProImmune Major Histocompatibility Complex Product
Table 65. ProImmune Revenue in Major Histocompatibility Complex Business (2024-2024) & (US$ Million)
Table 66. ProImmune Recent Development
Table 67. Creative BioMart Company Detail
Table 68. Creative BioMart Business Overview
Table 69. Creative BioMart Major Histocompatibility Complex Product
Table 70. Creative BioMart Revenue in Major Histocompatibility Complex Business (2024-2024) & (US$ Million)
Table 71. Creative BioMart Recent Development
Table 72. Novus Biologicals Company Detail
Table 73. Novus Biologicals Business Overview
Table 74. Novus Biologicals Major Histocompatibility Complex Product
Table 75. Novus Biologicals Revenue in Major Histocompatibility Complex Business (2024-2024) & (US$ Million)
Table 76. Novus Biologicals Recent Development
Table 77. Research Programs/Design for This Report
Table 78. Key Data Information from Secondary Sources
Table 79. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Major Histocompatibility Complex Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Major Histocompatibility Complex Market Share by Type: 2022 VS 2034
Figure 3. MHC Class I Features
Figure 4. MHC Class II Features
Figure 5. MHC Class III Features
Figure 6. Global Major Histocompatibility Complex Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Major Histocompatibility Complex Market Share by Application: 2022 VS 2034
Figure 8. Medical Care Case Studies
Figure 9. Research Case Studies
Figure 10. Other Case Studies
Figure 11. Major Histocompatibility Complex Report Years Considered
Figure 12. Global Major Histocompatibility Complex Market Size (US$ Million), Year-over-Year: 2024-2034
Figure 13. Global Major Histocompatibility Complex Market Size, (US$ Million), 2024 VS 2022 VS 2034
Figure 14. Global Major Histocompatibility Complex Market Share by Region: 2022 VS 2034
Figure 15. Global Major Histocompatibility Complex Market Share by Players in 2022
Figure 16. Global Top Major Histocompatibility Complex Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Major Histocompatibility Complex as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Major Histocompatibility Complex Revenue in 2022
Figure 18. North America Major Histocompatibility Complex Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 19. North America Major Histocompatibility Complex Market Share by Country (2024-2034)
Figure 20. United States Major Histocompatibility Complex Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 21. Canada Major Histocompatibility Complex Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 22. Europe Major Histocompatibility Complex Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 23. Europe Major Histocompatibility Complex Market Share by Country (2024-2034)
Figure 24. Germany Major Histocompatibility Complex Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 25. France Major Histocompatibility Complex Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 26. U.K. Major Histocompatibility Complex Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 27. Italy Major Histocompatibility Complex Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 28. Russia Major Histocompatibility Complex Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 29. Nordic Countries Major Histocompatibility Complex Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 30. Asia-Pacific Major Histocompatibility Complex Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 31. Asia-Pacific Major Histocompatibility Complex Market Share by Region (2024-2034)
Figure 32. China Major Histocompatibility Complex Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 33. Japan Major Histocompatibility Complex Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 34. South Korea Major Histocompatibility Complex Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 35. Southeast Asia Major Histocompatibility Complex Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 36. India Major Histocompatibility Complex Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 37. Australia Major Histocompatibility Complex Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 38. Latin America Major Histocompatibility Complex Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 39. Latin America Major Histocompatibility Complex Market Share by Country (2024-2034)
Figure 40. Mexico Major Histocompatibility Complex Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 41. Brazil Major Histocompatibility Complex Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 42. Middle East & Africa Major Histocompatibility Complex Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 43. Middle East & Africa Major Histocompatibility Complex Market Share by Country (2024-2034)
Figure 44. Turkey Major Histocompatibility Complex Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 45. Saudi Arabia Major Histocompatibility Complex Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 46. Miltenyi Biotec Revenue Growth Rate in Major Histocompatibility Complex Business (2024-2024)
Figure 47. Santa Cruz Biotechnology Revenue Growth Rate in Major Histocompatibility Complex Business (2024-2024)
Figure 48. Abbexa Revenue Growth Rate in Major Histocompatibility Complex Business (2024-2024)
Figure 49. ProImmune Revenue Growth Rate in Major Histocompatibility Complex Business (2024-2024)
Figure 50. Creative BioMart Revenue Growth Rate in Major Histocompatibility Complex Business (2024-2024)
Figure 51. Novus Biologicals Revenue Growth Rate in Major Histocompatibility Complex Business (2024-2024)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed